Why Procept BioRobotics Corp (PRCT) Stock Is Rising
As of 2026-10-12, Procept BioRobotics Corp (PRCT) has a next-year EPS growth estimate of 31.13%. Featured in our EPS revision report on 2026-10-12.
Why PRCT Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Procept BioRobotics Corp's next-year EPS growth estimate from 32.04% to 32.08% on 2026-10-05.
- ·Current-Year Growth: Projected at 2.77%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 31.13%
- EPS growth this year
- 2.77%
- EPS next quarter (est)
- -$0.39
- Last price
- $19.57
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-12 | 31.13% | 2.77% | -$0.39 | $19.57 |
| 2026-10-11 | 31.14% | 2.77% | -$0.39 | $18.40 |
| 2026-10-10 | 31.14% | 2.77% | -$0.39 | $18.40 |
| 2026-10-09 | 31.14% | 2.77% | -$0.39 | $18.40 |
| 2026-10-08 | 31.10% | 2.77% | -$0.39 | $17.90 |
| 2026-10-07 | 31.10% | 2.77% | -$0.39 | $17.91 |
| 2026-10-06 | 32.08% | 2.89% | -$0.39 | $17.51 |
| 2026-10-05 | 32.08% | 2.89% | -$0.39 | $17.82 |
| 2026-10-04 | 32.04% | 2.89% | -$0.39 | $17.16 |
| 2026-10-03 | 32.04% | 2.89% | -$0.39 | $17.16 |
| 2026-10-02 | 32.04% | 2.89% | -$0.39 | $17.16 |
| 2026-10-01 | 32.04% | 2.89% | -$0.39 | $17.02 |
| 2026-09-30 | 32.04% | 2.89% | -$0.39 | $18.22 |
| 2026-09-29 | 32.04% | 2.89% | -$0.39 | $18.22 |
| 2026-09-28 | 32.04% | 2.89% | -$0.39 | $17.25 |
| 2026-09-27 | 32.04% | 2.89% | -$0.39 | $17.20 |
| 2026-09-25 | 32.04% | 2.89% | -$0.39 | $17.20 |
| 2026-09-24 | 32.04% | 2.89% | -$0.39 | $17.50 |
| 2026-09-23 | 32.04% | 2.89% | -$0.39 | $18.09 |
| 2026-09-22 | 32.04% | 2.89% | -$0.39 | $18.43 |
| 2026-09-21 | 32.04% | 2.89% | -$0.39 | $18.51 |
| 2026-09-20 | 32.04% | 2.89% | -$0.39 | $19.30 |
| 2026-09-18 | 32.04% | 2.89% | -$0.39 | $19.30 |
| 2026-09-17 | 32.04% | 2.89% | -$0.39 | $19.47 |
| 2026-09-16 | 32.04% | 2.89% | -$0.39 | $19.44 |
| 2026-09-15 | 32.04% | 2.89% | -$0.39 | $19.30 |
| 2026-09-14 | 32.04% | 2.89% | -$0.39 | $21.02 |
| 2026-09-13 | 32.04% | 2.89% | -$0.39 | $20.38 |
| 2026-09-11 | 32.04% | 2.89% | -$0.39 | $20.38 |
| 2026-09-10 | 32.04% | 2.89% | -$0.39 | $20.07 |
Reports Featuring PRCT
Recent News
- Kaplan Fox Encourages PROCEPT BioRobotics Corporation (PRCT) Investors Who Suffered Losses to Seek a Leadership Role Before September 22, 2026Newsfile
- PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & JuneGlobeNewswire
- PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...GuruFocus.com
- PROCEPT BioRobotics Reports First Quarter 2026 Financial ResultsGlobeNewswire
Screen Performance
Aggregate stats across all 2080 tickers our top-EPS-revision screen has flagged over the past 194 days.
- Median return since detection
- -1.2%
- % of tickers in the green
- 46%
- Median return on winners
- +22.7%
- Large revisions captured
- 1859
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Procept BioRobotics Corp (PRCT) stock go up recently?▾
Procept BioRobotics Corp (PRCT) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 32.04% to 32.08% on 2026-10-05. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Procept BioRobotics Corp's next-year EPS growth estimate?▾
As of 2026-10-12, Procept BioRobotics Corp (PRCT) has a next-year EPS growth estimate of 31.13%, based on analyst consensus.
When was the latest EPS estimate revision for PRCT?▾
The most recent revision occurred on 2026-10-12, when analysts adjusted the next-year EPS growth estimate from 31.14% to 31.13%.
What sector and industry does Procept BioRobotics Corp belong to?▾
Procept BioRobotics Corp operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PRCT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Procept BioRobotics Corp (PRCT) appears here because it was detected by our daily top-EPS-revision-performer screen.